Roche’s Infinity model: Helping to transform the lives of patients with rare diseases

Anne Nijs explains how the rare-disease group at Roche Pharmaceuticals pioneered a new model that puts the patient experience at the center of healthcare innovation and delivery.
Roche’s Infinity model: Helping to transform the lives of patients with rare diseases